NCT05904457 A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer Status RECRUITING Phase PHASE2
NCT05877651 MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy. Status COMPLETED Phase PHASE1
NCT05839600 A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer Status TERMINATED Phase PHASE1
NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05740215 Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT05731947 Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05668585 A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors Status COMPLETED Phase PHASE1
NCT05650242 A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05648994 TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05644626 Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants Status WITHDRAWN Phase PHASE1
NCT05613036 A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body Status COMPLETED Phase PHASE1
NCT05600933 Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Status ENROLLING_BY_INVITATION Phase N/A
NCT05536141 A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT05522582 Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05512377 Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder Status TERMINATED Phase PHASE2
NCT05503797 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations Status RECRUITING Phase PHASE2
NCT05490472 JAB-2485 Activity in Adult Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05471856 A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours) Status RECRUITING Phase PHASE1
NCT05419817 Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System Status WITHDRAWN Phase PHASE2